Back to YC Companies
Nabla Bio
Summer 2020
Active
We use AI to design antibodies for intractable diseases
8 people View on YC
Nabla Bio at a glance
- Y Combinator batch
- Summer 2020
- Status
- Active
- Industry
- Healthcare
- Team size
- 8 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Nabla Bio
Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
Tags:
AI-powered Drug Discovery